In conclusion, the present data indicated for the first time that miR-342 expression is positively correlated with the expression of ERα mRNA in human breast cancer tissues and that the introduction of miR-342 into estrogen-dependent breast cancer cells enhances tamoxifen sensitivity. This evidence concerns the gene ESR1 and breast cancer.